Operating Lease, Liability of Immix Biopharma, Inc. from 31 Mar 2024 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Immix Biopharma, Inc. quarterly Operating Lease, Liability in USD history and change rate from 31 Mar 2024 to 30 Sep 2025.
Immix Biopharma, Inc. Operating Lease, Liability for the quarter ending 30 Sep 2025 was $1,106,335, a 1.6% increase year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

Immix Biopharma, Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$1,106,335	+$17,280	+1.6%	30 Sep 2025	10-Q	07 Nov 2025	2025	Q3
Q2 2025	$1,042,802	-$48,360	-4.4%	30 Jun 2025	10-Q	08 Aug 2025	2025	Q2
Q1 2025	$1,058,943	-$34,285	-3.1%	31 Mar 2025	10-Q	08 May 2025	2025	Q1
Q4 2024	$1,074,770			31 Dec 2024	10-Q	07 Nov 2025	2025	Q3
Q3 2024	$1,089,055			30 Sep 2024	10-Q	12 Nov 2024	2024	Q3
Q2 2024	$1,091,162			30 Jun 2024	10-Q	12 Aug 2024	2024	Q2
Q1 2024	$1,093,228			31 Mar 2024	10-Q	09 May 2024	2024	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.